Top compounds associated with response to RANGRF


Feature Type Standardized
Nominal ANOVA
mRNA manumycin A CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA Gemcitabine gCSI pan-cancer AAC 0.2 0.0003
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Doxorubicin gCSI pan-cancer AAC 0.19 0.0003
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.13 0.0003
mRNA BMS-345541 GDSC1000 pan-cancer AAC 0.12 0.0004
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA PD318088 CTRPv2 pan-cancer AAC -0.13 0.0004
Download CSV